{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:38:18Z","timestamp":1773920298159,"version":"3.50.1"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>We report a case of IgG \u03bb\u2013type multiple myeloma (MM) in a patient who received multiple lines of therapy and achieved repeated remissions. In 2025, the patient experienced a third relapse and had been exposed to proteasome inhibitors (PIs), immunomodulatory drugs (IMiDs), and anti-CD38 monoclonal antibodies (mAbs), meeting the criteria for triple-refractory disease. At relapse, the patient presented with fatigue and progressive anemia, and peripheral blood smear examination revealed approximately 14% atypical plasma cells, fulfilling the diagnostic criteria for secondary plasma cell leukemia (sPCL). Treatment with the KXD regimen (carfilzomib, cyclophosphamide, dexamethasone) resulted in transient disease stabilization for approximately two months, followed by further progression. During the disease course, the patient developed upper abdominal discomfort. Gastroscopy revealed a focal lesion at the gastric angle, and endoscopic submucosal dissection (ESD) was subsequently performed. Histopathological examination demonstrated a moderately differentiated intramucosal papillary adenocarcinoma of the gastric angle, with tumor infiltration confined to the mucosal layer and negative resection margins. In addition, infiltration of CD138-positive plasma cell\u2013like tumor cells with \u03bb light chain restriction was observed in the gastric lamina propria, consistent with extramedullary disease (EMD). The final diagnosis was relapsed MM complicated by sPCL, gastric mucosal extramedullary plasmacytic infiltration, and synchronous moderately differentiated intramucosal papillary adenocarcinoma.<\/jats:p>","DOI":"10.3389\/fonc.2026.1793707","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:50:58Z","timestamp":1773903058000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple myeloma associated with secondary plasma cell leukemia, gastric mucosal extramedullary plasmacytic infiltration, and concurrent moderately differentiated papillary adenocarcinoma: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Lulu","family":"Li","sequence":"first","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Yu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Bai","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueli","family":"Liu","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Cui","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02654-y","article-title":"Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders","volume":"39","author":"Zanwar","year":"2025","journal-title":"Leukemia"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.287158","article-title":"Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large us cohort study","volume":"110","author":"Singh","year":"2025","journal-title":"Haematologica"},{"key":"B4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41408-021-00587-0","article-title":"Primary plasma cell leukemia: consensus definition by the international myeloma working group according to peripheral blood plasma cell percentage","volume":"11","author":"Fern\u00e1ndez de Larrea","year":"2021","journal-title":"Blood Cancer J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32030182","article-title":"Extramedullary multiple myeloma: challenges and opportunities","volume":"32","author":"Ho","year":"2025","journal-title":"Curr Oncol (Toronto Ont)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41408-022-00643-3","article-title":"Extramedullary disease in multiple myeloma: A systematic literature review","volume":"12","author":"Blad\u00e9","year":"2022","journal-title":"Blood Cancer J"},{"key":"B7","article-title":"Clinical and biological features of multiple myeloma involving the gastrointestinal system","volume":"91","author":"Talamo","year":"2006","journal-title":"Haematologica"},{"key":"B8","article-title":"Total gastrectomy for gastric invasion of multiple myeloma-a case report","volume":"50","author":"Miyamoto","year":"2023","journal-title":"Jpn J Cancer Chemother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2023.01.001","article-title":"Relapsed multiple myeloma with gastric and pancreatic extramedullary plasmacytomas","volume":"122","author":"Lin","year":"2023","journal-title":"J Formosan Med Assoc"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2596-z","article-title":"Gastric involvement, a rare site for extramedullary myeloma","volume":"95","author":"Kusano","year":"2016","journal-title":"Ann Hematol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000004299","article-title":"A rare extramedullary involvement site in patients with multiple myeloma: stomach","volume":"47","author":"G\u00fclbahar Ate\u015f","year":"2022","journal-title":"Clinical Nuclear Medicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw606","article-title":"Second primary Malignancies in multiple myeloma: an overview and imwg consensus","volume":"28","author":"Musto","year":"2017","journal-title":"Ann Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217697","article-title":"Concomitant multiple myeloma, gastric adenocarcinoma and evan\u2019s syndrome in a patient presenting with anaemia","volume":"2016","author":"Al-Ammari","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4816","article-title":"Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts-a follow-up","volume":"11","author":"Holler","year":"2022","journal-title":"Cancer Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411259","article-title":"Genetic abnormalities in extramedullary multiple myeloma","volume":"24","author":"McAvera","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","article-title":"Clonal cytogenetics changes in progression of multiple myelomato extramedullary relapse and plasmocellular leukemia: A casereport","volume":"9","author":"Smetana","year":"2016","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1793707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:50:59Z","timestamp":1773903059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1793707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":16,"alternative-id":["10.3389\/fonc.2026.1793707"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1793707","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"1793707"}}